UTHSC In the Media


Neffy CEO: Why FDA Rejection of Epi Nasal Spray Was a Shocker

In the Media Icon

Dr. Jay Lieberman, an allergist-immunologist at University of Tennessee Health Science Center, said studies show neffy should work comparably to auto-injectors during allergic reactions.


Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research

In the Media Icon

Kathryn Wellen, PhD, professor of Cancer Biology at the University of Pennsylvania, and Liza Makowski, PhD, professor of Medicine in Hematology-Oncology at the University of Tennessee Health Science Center, are also co-principal investigators on the Endeavor Award team.


University of Tennessee Health Science Center to improve SCD care

In the Media Icon

The University of Tennessee Health Science Center’s College of Nursing has secured a grant from the United States Department of Agriculture (USDA) to improve emergency care for people with sickle cell disease (SCD) in the Mid-South Delta region.


Early onset CRC mortality in southern US linked to poor food environment

In the Media Icon

“Since the 1980s, there has been an increase in the incidence of early-onset colorectal cancer for those younger than age 50,” William K. Oelsner, MD, from the University of Tennessee Health Science Center, said at the ACG Annual Scientific Meeting. “This incidence is set to double by 2030. While the exact mechanism for this rise is still… Read More


Study Led by Fellow Shows Heart Health Risks of “Die-Hard” Sports Fans

In the Media Icon

Dr. Maturana earned his medical degree from the University of Valparaíso, Chile, and completed his residency in Internal Medicine at the University of Tennessee Health Science Center. Now, Dr. Maturana, is a chief cardiology fellow in the Department of Internal Medicine in the UTHSC College of Medicine.


Novel scoring tool predicts alcohol relapse after liver transplant with 96.2% sensitivity

In the Media Icon

“Alcohol relapse after liver transplant for alcoholic liver disease is frequent, with incidence ranging from 4% to 95% of LT recipients,” Jiten P. Kothadia, MD, a transplant hepatologist at the University of Tennessee Health Science Center, told Healio. “This leads to poor graft function, low medication adherence and decreased overall survival.”


Erlanger Medical Group adds 3 physicians to the team

In the Media Icon

Erlanger Medical Group announce the addition of Drs. Leahanne Giffin, Taylor Millirons and Hannah West to Erlanger Internal Medicine and Erlanger Primary Care. Dr. Giffin is a board-certified internal medicine physician with Erlanger Internal Medicine.


Higher Education Grants or Gifts of Interest to African Americans

In the Media Icon

Here is this week’s news of grants or gifts to historically Black colleges and universities or for programs of particular interest to African Americans in higher education. The College of Nursing at the University of Tennessee Health Science Center in Memphis has received a four-year, $4 million grant from the Health Resources and Services Administration to support… Read More